SOLACI Research Continues to Consolidate its Investigation Registries | REDCAP SOLACI

The Latin American Society of Interventional Cardiology has decided to hire the REDCap database platform to keep developing their research registries. 

In this regard, SOLACI’s Research Department continues to advance its mission of building clinical research lines to gather reliable information, which will allow us to define better therapeutic behaviors to adress the treatment of the different cardiovascular diseases in Latin America. 

At present, SOLACI Research is actively working on 3 registries. 

LATAM Bif Registry, carried out together with the Latin American Bifurcations Club, to assess the reality of coronary bifurcation treatment in Latin America,
SOLACI Peripheral Registry.
LATAM TAVI Registry.

Should you want to take part in any of SOLACI’s Registries, or should you wish to participate as a collaborator of the research departments, please write to research@solaci.org.

Let’s continue to strengthen the development of interventional cardiology in the region!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....